Nobuyuki Susumu - Gynecology

Author Information

Dr. Nobuyuki Susumu is affiliated with the Department of Obstetrics and Gynecology at the International University of Health and Welfare, located at 4-3, Kozunomori, Narita, Japan. His research predominantly focuses on gynecological oncology, with specific interests in clinical practice patterns, treatment efficacy, and genetic implications of various gynecological cancers.

Research Contributions

Dr. Nobuyuki Susumu has made significant contributions to the field of gynecology through his extensive research on gynecological cancers. Notable studies include the clinical practice patterns of sentinel lymph node biopsy, the safety and efficacy of high-dose luteal hormone therapy for recurrent early-stage endometrial cancer, and the clinical implications of next-generation sequencing for malignant ovarian tumors. His work also extends to the identification of genetic markers in uterine leiomyoma and the examination of prognostic factors in uterine leiomyosarcoma. Dr. Susumu's research has provided valuable insights into the diagnosis, treatment, and management of gynecological malignancies.

Aliases

N Susumu, N. Susumu, Nobuyuki Susumu

Publication and Citation Metrics

Publication Year	Title	DOI
2021	Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study	10.1007/s10147-021-01862-7
2021	JGOG2051: The safety and efficacy of repeated high-dose luteal hormone (MPA) therapy for recurrent early-stage endometrial cancer patients	10.3802/jgo.2021.32.s1.e11
2020	Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors	10.1002/cam4.3383
2020	Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome	10.1007/s13691-020-00449-9
2020	Identification of a novel uterine leiomyoma GWAS locus in a Japanese population	10.1038/s41598-020-58066-8
2020	Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma	10.1016/j.ygyno.2020.01.022
2019	Impact of preoperative hysteroscopy on outcomes of peritoneal cytology in patients with endometrial cancer	10.5795/jjscc.58.196
2019	Errattum to: Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review), (Biomed Rep), 1: 335-340, 2013	10.3892/BR.2019.1249
2019	Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)	10.3892/br.2019.1249
2019	Sentinel Node Navigation Surgery for Endometrial Cancer	10.1007/978-981-13-1519-0_19